Prenatal diagnosis of I-cell disease.
A pregnancy from a family in risk of I-cell disease was monitored. The fetus was diagnosed as having I-cell disease based on the findings that (1) lysosomal enzyme activities except for acid phosphatase and alpha glucosidase were clearly elevated in amniotic fluid and were reduced in cultivated amniotic fluid cells, and (2) cytoplasmic inclusions were seen in cultivated amniotic cells by phase contrast microscopy. The accuracy of prediction was confirmed by cultured skin fibroblast of the aborted fetus.
D000135:Acid Phosphatase / Q000032:analysis; D000328:Adult; D000649:Amniocentesis; D000653:Amniotic Fluid / Q000166:cytology / Q000201:enzymology; D001192:Arylsulfatases / Q000032:analysis; D004186:Disaccharidases / Q000032:analysis; D005260:Female; D005966:Glucuronidase / Q000032:analysis; D006596:Hexosaminidases / Q000032:analysis; D006801:Humans; D002479:Inclusion Bodies; D008064:Lipidoses / Q000175:diagnosis* / Q000201:enzymology; D008247:Lysosomes / Q000201:enzymology; D011247:Pregnancy
D000135:Acid Phosphatase; D001192:Arylsulfatases; D004186:Disaccharidases; D006596:Hexosaminidases; D005966:Glucuronidase